These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 497587)
1. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings]. Costall B; Hui SC; Naylor RJ Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587 [No Abstract] [Full Text] [Related]
2. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens. Morgenstern R; Fink H Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255 [TBL] [Abstract][Full Text] [Related]
3. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity. Van Ree JM; Wolterink G Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189 [No Abstract] [Full Text] [Related]
4. Effects of dopamine receptor agonists and antagonists in the rat nucleus acumbens [proceedings]. Freedman SB; Wait CP; Woodruff GN Br J Pharmacol; 1979 Nov; 67(3):430P-431P. PubMed ID: 497555 [No Abstract] [Full Text] [Related]
5. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats]. Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129 [TBL] [Abstract][Full Text] [Related]
6. [Circling behavior produced by the unilateral intra-accumbens injection of dopaminergic agonist and two dopaminergic antagonists in mice]. Mrabet O; Messier C; Destrade C C R Acad Sci III; 1989; 309(3):77-82. PubMed ID: 2504444 [TBL] [Abstract][Full Text] [Related]
7. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. Robbins TW; Roberts DC; Koob GF J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587 [TBL] [Abstract][Full Text] [Related]
8. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives. Gundlach AL; Christie MJ; Beart PM Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029 [TBL] [Abstract][Full Text] [Related]
9. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Radhakishun FS; Van Ree JM Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134 [TBL] [Abstract][Full Text] [Related]
10. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. Cools AR; Oosterloo SK J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148 [TBL] [Abstract][Full Text] [Related]
11. Evidence for dopamine receptors on GABA-releasing nerve terminals in rat nucleus accumbens [proceedings]. Beart PM; Kuppers D; Louis WJ Br J Pharmacol; 1980 Jan; 68(1):160P-161P. PubMed ID: 7357173 [No Abstract] [Full Text] [Related]
12. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. Kalivas PW; Richardson-Carlson R; Duffy P J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755 [TBL] [Abstract][Full Text] [Related]
13. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens. Johnels B Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238 [TBL] [Abstract][Full Text] [Related]
14. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats. van Ree JM; Igarashi J; Király I NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632 [TBL] [Abstract][Full Text] [Related]
15. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat. Kafetzopoulos E Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447 [TBL] [Abstract][Full Text] [Related]
16. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens. Morgenstern R; Fink H J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521 [TBL] [Abstract][Full Text] [Related]
17. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health. Wray SR; Melville GN; Wenger T; Louden D West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399 [No Abstract] [Full Text] [Related]
18. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections. Costall B; Domeney AM; Naylor RJ Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677 [TBL] [Abstract][Full Text] [Related]
19. The response of apomorphine administered into the accumbens in rats with bilateral lesions of the nucleus accumbens, induced with 6-hydroxydopamine. Radhakishun FS; Wolterink G; van Ree JM Neuropharmacology; 1988 Nov; 27(11):1111-6. PubMed ID: 3144656 [TBL] [Abstract][Full Text] [Related]
20. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens. Vance MA; Blumberg JB Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]